Regenerative Medicine’s Big Bet: Putting an End to Injury Pain
July 6, 2015
(CNBC) – This field of research—referred to as regenerative medicine and expected to mature into a $24.7 billion market by 2017, according to at least one estimate—is gaining more attention because of its unique pain alleviation methods. The linchpin of the field is the use of stem cells, which can be applied to a range of therapies for ligaments, tendons and skeletal injuries that affect sports players and non-athletes alike.